Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Reshape Biotech offers an advanced automation platform powered by robotics and AI, specifically designed for microbiology labs, which revolutionizes traditional plate-based assays into scalable and data-rich workflows that can be replicated consistently. Among its key offerings are the innovative "Smart Incubator," a high-throughput imaging system, and a cloud-based "Discovery Platform," all of which automatically capture detailed images of Petri dishes and microtiter plates during their incubation periods, subsequently uploading this data to the cloud for immediate AI-driven analysis. The platform excels in accurately processing various readouts, including colony counting, radial growth, fluorescence, turbidity, color assays, seed-germination traits, and antagonistic assays, thereby eliminating the need for labor-intensive manual observations and minimizing human errors. In addition to enhancing efficiency, Reshape's solution creates a consolidated, searchable repository for all experiments and datasets, empowering teams to compare outcomes across different experiments, foster collaboration among various labs, and maintain consistency and reproducibility, irrespective of the scale of operations. This transformative approach not only streamlines workflow but also significantly elevates the quality of research outputs in microbiological studies.
Description
By leveraging visual analytics through TIBCO Spotfire®, PerkinElmer Signals Translational offers a comprehensive suite of tools designed to harmonize, manage, search, aggregate, and analyze extensive datasets consistently for translational research, all while ensuring scalability. This platform, driven by TIBCO Spotfire®, supports precision medicine initiatives by providing an unparalleled solution for biomarker discovery and patient stratification. The Linear Mixed Effect App (LME) within Signals Translational empowers researchers to evaluate the influence of various factors on specific phenotypes, allowing for adjustments related to random variables during analysis. Furthermore, it enables the identification of genes significantly affecting cancer stage progression, irrespective of patient origins. Notably, the LME models excel at addressing issues such as missing values and outliers, making them a robust choice for discovering potential biomarkers. Consequently, the integration of these advanced analytics tools enhances the efficacy of translational research in identifying key biomarkers that can lead to more personalized treatment approaches.
API Access
Has API
Yes
API Access
Has API
No
Integrations
Signals Research Suite
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
No
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
Yes
Mac
Yes
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
No
Vendor Details
Company Name
Reshape
Founded
2018
Country
Denmark
Website
www.reshapebiotech.com
Vendor Details
Company Name
PerkinElmer
Founded
1937
Country
United States
Website
perkinelmerinformatics.com/products/clinical-translational/signals-translational/